Valuation: Exact Sciences Corporation

Market Cap 2TCr 1.76TCr 1.62TCr 1.49TCr 2.82TCr 1,93100Cr 2.86TCr 19TCr 7.61TCr 94TCr 7.52TCr 7.36TCr 3,25500Cr P/E 2024
-10.1x
P/E 2025 -92.2x
Enterprise Value 2.16TCr 1.89TCr 1.75TCr 1.61TCr 3.04TCr 2,08300Cr 3.09TCr 21TCr 8.2TCr 1,01900Cr 8.11TCr 7.93TCr 3,51100Cr EV / Sales 2024
4.4x
EV / Sales 2025 6.42x
Free-Float
98.24%
Yield 2024 *
-
Yield 2025 -
1 day+0.95%
6 months+2.50%
Current year+3.30%
Current year 101.51
Extreme 101.51
104.98
1 year 38.81
Extreme 38.8118
104.98
3 years 38.81
Extreme 38.8118
104.98
5 years 29.27
Extreme 29.27
119.1
10 years 11.96
Extreme 11.96
159.54
Date Insider Type Main position Quantity % Market Cap.
23/03/26 Free

Chief Executive Officer

25,33,955 1.3275%
23/03/26 Issuer sale

General Counsel

93,932 0.0492%
23/03/26 Issuer sale

Chief Administrative Officer

90,092 0.0472%
Change 5-day change 1-year change 3-year change Capi.($)
+0.95%-.--%+107.91%+10.51% 2TCr
-3.16%-0.38%+143.56%+104.35% 456.89Cr
-4.62%+4.00%+110.39%+183.90% 349.86Cr
+0.40%+24.26%+125.11%-34.12% 224.14Cr
-3.42%+33.41%+222.03%+282.55% 198.22Cr
+1.47%-0.36%-28.63%-36.47% 206.73Cr
-3.45%+9.91%+187.65%-44.17% 103.11Cr
-6.83%-6.50%-16.88%+25.47% 82Cr
-1.43%+7.14%-35.15%-11.76% 51Cr
-13.37%-17.95%-16.80% - 41Cr
Average -3.35%+5.21%+79.92%+53.36% 371.56Cr
Weighted average by Cap. -0.80%+3.62%+108.18%+46.49%

Financials

2024 2025
Net sales 275.89Cr 241.81Cr 223.52Cr 205.57Cr 387.88Cr 27TCr 394.1Cr 2.67TCr 1.05TCr 13TCr 1.04TCr 1.01TCr 45TCr 324.7Cr 284.6Cr 263.07Cr 241.95Cr 456.51Cr 31TCr 463.83Cr 3.15TCr 1.23TCr 15TCr 1.22TCr 1.19TCr 53TCr
Net income -102.89Cr -90Cr -83Cr -77Cr -144.65Cr -9.92TCr -146.97Cr -996.73Cr -390.72Cr -4.85TCr -386.34Cr -377.91Cr -17TCr -21Cr -18Cr -17Cr -15Cr -29Cr -2.01TCr -30Cr -201.45Cr -79Cr -981.15Cr -78Cr -76Cr -3.38TCr
Net Debt 173.77Cr 152.31Cr 140.79Cr 129.48Cr 244.31Cr 17TCr 248.23Cr 1.68TCr 659.91Cr 8.2TCr 652.51Cr 638.28Cr 28TCr 157.01Cr 137.62Cr 127.21Cr 117Cr 220.75Cr 15TCr 224.29Cr 1.52TCr 596.27Cr 7.41TCr 589.58Cr 576.72Cr 26TCr
Logo Exact Sciences Corporation
Exact Sciences Corporation is a provider of cancer screening and diagnostic tests. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. It is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
Employees
7,150
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
  1. Stock Market
  2. Stocks
  3. EXAS Stock